Table 3.
Therapy among enrolled patients.
| COVID-19 only (n = 400) | CAM (n = 33) | P value | |
|---|---|---|---|
| Cephalosporin | 192 (48%) | 9 (27.3%) | 0.01 |
| Quinolones | 204 (51%) | 16 (48.5%) | 0.46 |
| Averozolid | 48 (12%) | 6 (18.2%) | 0.21 |
| Teicoplanin | 40 (10%) | 0 | 0.03 |
| Carbapenems | 144 (36%) | 3 (9.1%) | < 0.001 |
| Other antibiotics | 8 (2%) | 0 | 0.52 |
| Steroid dose (mg) | 40 (40–200) | 160 (160–200) | < 0.001 |
Data expressed as frequency (percentage), median (range) as appropriate. P value was significant if < 0.05. Nominal data was compared by Chi-square test while continuous data was compared by Mann Whitney test.
CAM: covid associated mucormycosis.
Significant values are given in bold.